This project will evaluate the properties and physiological role of a novel phospholipase A{2} (aiPLA{2}) that is one of the enzymatic activities of the protein called peroxiredoxin 6. We have isolated the protein from rat and bovine lungs, have identified the full length cDNA for the human, rat, mouse and bovine enzyme, have generated recombinant protein, and have developed a panel of antibodies that are effective for western blotting, immunoprecipitation and immunocytochemistry. aiPLA{2} is Ca[++]-independent, shows maximal activity at pH 4, and represents a lysosomal-type PLA{2}. During the present period of grant support, we have shown that aiPLA{2}: 1) plays a major role in degradation of internalized alveolar DPPC;2) provides substrate for the reacylation pathway of DPPC synthesis;3) activity is regulated through protein-protein interactions with SP-A;4) is localized in lung to lamellar bodies and lysosomes;5) is activated by phosphorylation;and 6) its expression is developmentally regulated and hormonally responsive.
Specific Aim 1 will study models of under- and over-expression of aiPLA{2} (knockout and transgenic mice) in order to evaluate the physiologic role of the enzyme in DPPC degradation and synthesis using isolated cells, the isolated perfused lung, and in vivo studies. Time-related (aging) changes in lung phospholipid content will be determined.
Specific Aim 2 will evaluate the structure-function relationships for aiPLA{2} activity utilizing site directed mutagenesis and biophysical techniques to determine the role of the proposed catalytic triad, specificity of the enzyme for phospholipid substrates, and identification of the binding sites for its interaction with SP-A. X-ray crystallography will be utilized to provide additional insights into the spatial interactions of enzyme, substrate, and inhibitors.
Specific Aim 3 will evaluate the targeting motifs responsible for the subcellular localization of the enzyme utilizing deletion mutants. The subcellular localization determines the phospholipase (lysosomal) vs. peroxidase (cytoplasmic) activities of this protein.
Specific Aim 4 will investigate the regulation of Prdx6 activity with emphasis on the role of protein phosphorylation. A focus will be on the MAP kinase pathway and the specific phosphorylation sites on the protein. These studies will provide important insights into the role and regulation of a novel enzyme of major importance to lung surfactant metabolism and will provide the basis for further in depth characterization of the role of lysosomal PLA{2} activity in disease pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL019737-34
Application #
8112416
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
34
Fiscal Year
2010
Total Cost
$451,238
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hawkins, Arie; Guttentag, Susan H; Deterding, Robin et al. (2015) A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy. Am J Physiol Lung Cell Mol Physiol 308:L33-47
Chowdhury, Ibrul; Fisher, Aron B; Christofidou-Solomidou, Melpo et al. (2014) Keratinocyte growth factor and glucocorticoid induction of human peroxiredoxin 6 gene expression occur by independent mechanisms that are synergistic. Antioxid Redox Signal 20:391-402
Roszell, Blair R; Tao, Jian-Qin; Yu, Kevin J et al. (2013) Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease. PLoS One 8:e67084
Roszell, Blair R; Tao, Jian-Qin; Yu, Kevin J et al. (2012) Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung. Am J Physiol Lung Cell Mol Physiol 302:L919-32
Rahaman, Hamidur; Zhou, Suiping; Dodia, Chandra et al. (2012) Increased phospholipase A2 activity with phosphorylation of peroxiredoxin 6 requires a conformational change in the protein. Biochemistry 51:5521-30
Weibel, Ginny L; Joshi, Michelle R; Jerome, W Gray et al. (2012) Cytoskeleton disruption in J774 macrophages: consequences for lipid droplet formation and cholesterol flux. Biochim Biophys Acta 1821:464-72
Maguire, Jean Ann; Mulugeta, Surafel; Beers, Michael F (2012) Multiple ways to die: delineation of the unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutants. Int J Biochem Cell Biol 44:101-12
Zhang, Linghui; Yu, Kevin; Robert, Kyle W et al. (2011) Rab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells. Am J Physiol Lung Cell Mol Physiol 301:L461-77
Fisher, Aron B (2011) Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase Aýýý activities. Antioxid Redox Signal 15:831-44
Atochina-Vasserman, Elena N; Bates, Sandra R; Zhang, Peggy et al. (2011) Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome. Am J Respir Crit Care Med 184:449-58

Showing the most recent 10 out of 234 publications